| A PARACEST MRI contrast agent to detect enzyme activity B Yoo, MD Pagel Journal of the American Chemical Society 128 (43), 14032-14033, 2006 | 211 | 2006 |
| An overview of responsive MRI contrast agents for molecular imaging B Yoo, MD Pagel Front Biosci 13 (13), 1733, 2008 | 186 | 2008 |
| PARACEST MRI with improved temporal resolution G Liu, MM Ali, B Yoo, MA Griswold, JA Tkach, MD Pagel Magnetic Resonance in Medicine: An Official Journal of the International …, 2009 | 97 | 2009 |
| Investigation of jewelry powders radiating far-infrared rays and the biological effects on human skin BH Yoo, CM Park, TJ Oh, SH Han, HH Kang, IS Chang Journal of cosmetic science 53 (3), 175-184, 2002 | 93 | 2002 |
| Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI MM Ali, B Yoo, MD Pagel Molecular pharmaceutics 6 (5), 1409-1416, 2009 | 90 | 2009 |
| Enzyme‐responsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome B Yoo, MS Raam, RM Rosenblum, MD Pagel Contrast Media & Molecular Imaging 2 (4), 189-198, 2007 | 89 | 2007 |
| GLP-1R–targeting magnetic nanoparticles for pancreatic islet imaging P Wang, B Yoo, J Yang, X Zhang, A Ross, P Pantazopoulos, G Dai, ... Diabetes 63 (5), 1465-1474, 2014 | 77 | 2014 |
| Combining miR-10b–targeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancer B Yoo, A Kavishwar, A Ross, P Wang, DP Tabassum, K Polyak, ... Cancer research 75 (20), 4407-4415, 2015 | 69 | 2015 |
| Detection of in vivo enzyme activity with CatalyCEST MRI B Yoo, VR Sheth, CM Howison, MJK Douglas, CT Pineda, EA Maine, ... Magnetic Resonance in Medicine 71 (3), 1221-1230, 2014 | 62 | 2014 |
| Detecting enzyme activities with exogenous MRI contrast agents DV Hingorani, B Yoo, AS Bernstein, MD Pagel Chemistry–A European Journal 20 (32), 9840-9850, 2014 | 52 | 2014 |
| RNAi-mediated PD-L1 inhibition for pancreatic cancer immunotherapy B Yoo, VC Jordan, P Sheedy, AM Billig, A Ross, P Pantazopoulos, ... Scientific Reports 9 (1), 4712, 2019 | 47 | 2019 |
| Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ B Yoo, MA Ifediba, S Ghosh, Z Medarova, A Moore Molecular imaging and biology 16, 680-689, 2014 | 45 | 2014 |
| Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer B Yoo, A Kavishwar, P Wang, A Ross, P Pantazopoulos, M Dudley, ... Scientific reports 7 (1), 45060, 2017 | 43 | 2017 |
| Clinical applications of short non-coding RNA-based therapies in the era of precision medicine ES Smith, E Whitty, B Yoo, A Moore, LF Sempere, Z Medarova Cancers 14 (6), 1588, 2022 | 39 | 2022 |
| An amine-derivatized, DOTA-loaded polymeric support for Fmoc solid phase peptide synthesis B Yoo, VR Sheth, MD Pagel Tetrahedron letters 50 (31), 4459-4462, 2009 | 36 | 2009 |
| Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells Z Medarova, P Pantazopoulos, B Yoo Scientific reports 10 (1), 1970, 2020 | 34 | 2020 |
| Design of nanodrugs for miRNA targeting in tumor cells B Yoo, SK Ghosh, M Kumar, A Moore, MV Yigit, Z Medarova Journal of biomedical nanotechnology 10 (6), 1114-1122, 2014 | 32 | 2014 |
| Peptidyl molecular imaging contrast agents using a new solid-phase peptide synthesis approach B Yoo, MD Pagel Bioconjugate chemistry 18 (3), 903-911, 2007 | 31 | 2007 |
| A facile synthesis of α-amino-DOTA as a versatile molecular imaging probe B Yoo, MD Pagel Tetrahedron letters 47 (41), 7327-7330, 2006 | 31 | 2006 |
| Fluorescent and lanthanide labeling for ligand screens, assays, and imaging JS Josan, CR De Silva, B Yoo, RM Lynch, MD Pagel, J Vagner, VJ Hruby Drug Design and Discovery: Methods and Protocols, 89-126, 2011 | 30 | 2011 |
